IMCR
Immunocore Holdings plcNASDAQHealthcare$30.83+1.72%ClosedMarket Cap: $1.56B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
4.22
P/S
4.34
EV/EBITDA
-3680.23
DCF Value
$-238.56
FCF Yield
-0.9%
Div Yield
0.0%
Margins & Returns
Gross Margin
98.7%
Operating Margin
-10.8%
Net Margin
-7.2%
ROE
-6.9%
ROA
-2.5%
ROIC
-4.9%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $77.4M | 96.6% | $-14.6M | $-22.3M | $-0.44 | — |
| FY 2025 | $297.6M | 97.9% | $-33.7M | $-26.4M | $-0.53 | — |
| Q3 2025 | $103.7M | 99.5% | $-7.2M | $785.0K | $0.02 | — |
| Q2 2025 | $98.0M | 98.9% | $-14.9M | $-10.3M | $-0.21 | — |
| Q1 2025 | $93.9M | 99.1% | $-3.6M | $5.0M | $0.10 | — |
| Q4 2024 | $84.1M | 99.6% | $-19.5M | $-23.8M | $-0.47 | — |
| FY 2024 | $248.0M | 97.8% | $-56.3M | $-40.8M | $-1.02 | — |
| Q3 2024 | $80.2M | 99.4% | $-8.5M | $8.7M | $0.17 | — |
| Q2 2024 | $75.4M | 97.7% | $-16.0M | $-11.6M | $-0.23 | — |
| Q1 2024 | $70.5M | 99.7% | $-26.5M | $-24.4M | $-0.49 | — |
| Q4 2023 | $56.0M | 99.7% | $-13.6M | $-15.7M | $-0.32 | — |
| FY 2023 | $197.4M | 99.6% | $-47.2M | $-43.8M | $-0.89 | — |